Anna Vasileva

205 posts

Anna Vasileva banner
Anna Vasileva

Anna Vasileva

@pathoblog

MD, Surgical Pathologist | Enthusiast in the Education of Junior Pathologists

加入时间 Mart 2020
850 关注858 粉丝
Аndrew
Аndrew@Andrew_Fltv·
F62, omentum with subtotal metastatic lesion. #Grosspath #GUpath #pathtwitter #pathology When the topic of the omentum hit the popular Twitter trends, I remembered my photos from the folder ‘serous ovarian carcinoma, HG’ 🙃
Аndrew tweet mediaАndrew tweet media
English
1
0
2
509
Anna Vasileva 已转推
Siba El Hussein, MD
Siba El Hussein, MD@SibaElHussein·
Illustration of a case of Follicular Lymphoma with Hyaline Vascular Unicentric Castleman Disease-"like" changes➡️ 🩸Depleted germinal centers (Fig 2) 🩸Onion-skinning of mantle zones (Fig 2-3) 🩸Penetrating hyalinized vessels, imparting a lollipop-like configuration of germinal centers (Fig 3) 🩸Twinning (fusion) of follicles (Fig 4) This case turned out to be postive for BCL2 translocation by FISH, with an aberrant CD10-positive population by flow cytometry analysis. More on this variant of Follicular Lymphoma➡️pubmed.ncbi.nlm.nih.gov/28873356/ To complicate things, the "follicular variant" of Hyaline Vascular Unicentric Castleman Disease, with characteristic back-to-back follicular architecture, may greatly mimic follicular lymphoma as well ➡️pubmed.ncbi.nlm.nih.gov/8116226/ ➡️pubmed.ncbi.nlm.nih.gov/19039195/ In summary, by morphologic examination, Follicular Lymphoma may present like Hyaline Vascular Unicentric Castleman Disease; Conversly, Hyaline Vascular Unicentric Castleman Disease may show a presentation very similar to Follicular Lymphoma #hemepath #lymsm #PathX #PathTwitter #MedX #MedTwitter #MedEd
Siba El Hussein, MD tweet mediaSiba El Hussein, MD tweet mediaSiba El Hussein, MD tweet mediaSiba El Hussein, MD tweet media
English
1
47
119
6.6K
Anna Vasileva 已转推
Gladell Paner, MD
Gladell Paner, MD@GladellPaner·
For our 2023 #pathology trainees, remember this #GUPath adage👇 “Not all renal tumors with clear cells are clear cell renal cell carcinoma” … spot on in this molecular era! 👇Below are DDX for Clear cell #RCC including #renal tumors with some degree of cytoplasmic clearing🔬
Gladell Paner, MD tweet media
English
3
128
268
16.3K
Anna Vasileva 已转推
Jonathan A. Nowak
Jonathan A. Nowak@jonathan_nowak·
Targeted therapies for colorectal cancer have advanced greatly since my last review on this subject in 2016 with the incomparable @JLHornick. MMR deficiency, high TMB, BRAF, HER2 and numerous rearrangements have all become targetable.
Jonathan A. Nowak tweet media
English
1
15
42
4K
Anna Vasileva
Anna Vasileva@pathoblog·
@atman_ci I’m very glad that the case turned out to be educational! Thanks for sharing 🙏🏻
English
0
0
1
38
Anna Vasileva 已转推
Fouad Boulos
Fouad Boulos@fouad_boulos·
One in a million Monday. Unwittingly saved by the clinician. This case was not a consult, it was just a good old biopsy from a satellite hospital for whose patients we provide pathology diagnostic services. In that hospital, breast surgeons coordinate breast patient care, perform biopsies, discuss treatment and surgical plans with patients, and eventually refer to oncology as needed. Unlike our radiologists and oncologists here at WashU, the surgeons at that hospital do not want to get a tumor diagnosis then get an addendum with the biomarkers. They like to see a complete report all at once. I can't say I dislike that practice, and after this particular case, I like it even more, because it saved me from a major (albeit exceptionally rare) misdiagnosis. The images below depict a tumor I was squarely going to call invasive solid papillary carcinoma because, to my eyes, that's exactly what it looks like. Except that's not what it is. And because I waited for the biomarkers to sign it out, I was fortunate to find out it was triple negative, which would be extremely unusual for solid papillary carcinoma. So, I contacted the surgeon and dug into her chart, and sure enough, the patient had a history of metastatic mucoepidermoid carcinoma of the minor salivary glands. That's when I started seeing a hint of squamous differentiation and possible mucous cells. CK5/6 and p63 were done and were confirmatory. MAML2 FISH was also positive and sealed the deal. I did not find a similar case in the literature. Lessons from this monumental near miss. 1. Clinician preferences did save me this time, but the clinician's omission of pertinent medical history is a common and persistent problem. 2. Always remember that breast biomarkers are not only predicitve and prognostic, but also diagnostic. If their pattern does not fit with the tumor's morphology, take a deep breath and dive into those muddy diagnostic waters. 3. Again and again, be vigilant, look for clinical information, don't make assumptions. Easier said than done, of course, and I do not want to encourage paranoia because I am not the paranoid type, but sharp alertness is one absolute must, and not allowing hasty explanations for things that don't quite fit is another. 4. Morphology is key, but nature loves mimicry. Don't be a hammer. Everything is not a nail. @washupathedu @wusm_pathology #PathTwitter #Breastpath #ENTpath
Fouad Boulos tweet mediaFouad Boulos tweet mediaFouad Boulos tweet mediaFouad Boulos tweet media
English
21
79
211
26.6K
B 🔬
B 🔬@Ba_P10·
@pathoblog Waaaoo ! Great case and nice pictures 🙏
English
1
0
1
53
Anna Vasileva 已转推
Janira Navarro
Janira Navarro@Janiranavarro·
Ovary Sertoli-Leydig cell tumor Grade of differentiation -Tubular differentiation of the Sertoli cell component (decreasing with increasing grade) -Quantity of primitive gonadal stroma (increasing with increasing grade) -Leydig cells also decrease with increasing grade WHO and DAPA GR #EverydayGYN #gynpath #PathTwitter #pathologists #pathresidents #pathfellow
Janira Navarro tweet media
English
2
25
81
5.3K